Molecular mechanism and therapeutic strategy for cerebral small vessel disease

Clinical Neurology

Volumn 50, Issue 11, 2010, Pages 852-854

  Hara, Kenju ^a,b  

^a AKITA RED CROSS HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

CARASIL; HtrA1; Marfan's syndrome; Small vessel disease; TGF signal transduction

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; HTRA1 ENZYME; MATRIX PROTEIN; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

CADASIL; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE MUTATION; GENOME ANALYSIS; HEREDITY; HUMAN; HYPERTENSION; LEUKOARAIOSIS; MARFAN SYNDROME; MOLECULAR MECHANICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; SIGNAL TRANSDUCTION; VASCULAR FIBROSIS; WHITE MATTER;

CADASIL; CEREBRAL SMALL VESSEL DISEASES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MARFAN SYNDROME; MICROFILAMENT PROTEINS; MOLECULAR TARGETED THERAPY; MUTATION; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84856403508     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.50.852     Document Type: Conference Paper

References (10)

1. Markus HS. Unravelling the genetics of ischemic stroke. PLoS Med 2010;7:e1000225.
2. Arima K, Yanagawa S, Ito N, et al. Cerebral arterial pathology of CADASIL and CARASIL (Maeda syndrome). Neuropathology 2003;23:327-334. (Pubitemid 38004867)
3. Hara K, Shiga A, Fukutake T, et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med 2009;360:1729-1739.
4. Oka C, Tsujimoto R, Kajikawa M, et al. HtrA1 serine protease inhibits signaling mediated by Tgfß family proteins. Development 2004;131:1041-1053. (Pubitemid 38380458)
5. Ten Dijke P, Arthur HM. Extracellular control of TGFbeta signaling in vascular development and disease. Nat Rev Mol Cell Biol 2007;11:857-869. (Pubitemid 47622560)
6. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-1358. (Pubitemid 30408720)
7. Gelb BD. Marfan's syndrome and related disorders - more tightly connected than we thought. N Engl J Med 2006;355:841-844. (Pubitemid 44285590)
8. Ahimastos AA, Aggarwal A, D'Orsa KM, et al. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA 2007;298:1539-1547. (Pubitemid 47529388)
9. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome. Science 2006;312:117-121.
10. Brooke BS, Habashi JP, Judge JP, et al. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 2008;358:2787-2795. (Pubitemid 351930853)